We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$3B
AUM Growth
-$104M
Cap. Flow
-$35.7M
Cap. Flow %
-1.19%
Top 10 Hldgs %
32.3%
Holding
3,551
New
192
Increased
1,349
Reduced
1,018
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 15.35%
2 Healthcare 9.27%
3 Financials 6.89%
4 Consumer Discretionary 4.69%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERAS icon
2851
Erasca
ERAS
$6.39B
$1.82K ﹤0.01%
922
+770
+507% +$1.97K
CEQP
2852
DELISTED
Crestwood Equity Partners LP
CEQP
$1.81K ﹤0.01%
62
BVN icon
2853
Compañía de Minas Buenaventura
BVN
$8.67B
$1.81K ﹤0.01%
212
+138
+186% +$1.11K
ALLO icon
2854
Allogene Therapeutics
ALLO
$694M
$1.8K ﹤0.01%
568
+230
+68% +$1.01K
ICUI icon
2855
ICU Medical
ICUI
$4.61B
$1.78K ﹤0.01%
15
+10
+200% +$1.49K
NVRO
2856
DELISTED
NEVRO CORP.
NVRO
$1.77K ﹤0.01%
+92
New +$1.96K
FCBC icon
2857
First Community Bankshares
FCBC
$911M
$1.77K ﹤0.01%
60
+36
+150% +$1.13K
WVVI icon
2858
Willamette Valley Vineyards
WVVI
$11.9M
$1.76K ﹤0.01%
300
TAC icon
2859
TransAlta
TAC
$3.93B
$1.72K ﹤0.01%
198
CPE
2860
DELISTED
Callon Petroleum Company
CPE
$1.72K ﹤0.01%
44
SRVR icon
2861
Pacer Data & Infrastructure Real Estate ETF
SRVR
$381M
$1.71K ﹤0.01%
66
-332
-83% -$9.48K
ODP
2862
DELISTED
ODP
ODP
$1.71K ﹤0.01%
37
-13
-26% -$625
CNDT icon
2863
Conduent
CNDT
$264M
$1.71K ﹤0.01%
490
-1
-0.2% -$3
LFCR icon
2864
Lifecore Biomedical
LFCR
$190M
$1.7K ﹤0.01%
225
IBRX icon
2865
ImmunityBio
IBRX
$8.1B
$1.69K ﹤0.01%
+1,000
New +$2.01K
INFN
2866
DELISTED
Infinera Corporation Common Stock
INFN
$1.69K ﹤0.01%
403
-357
-47% -$1.54K
ABEO icon
2867
Abeona Therapeutics
ABEO
$413M
$1.68K ﹤0.01%
400
FTA icon
2868
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.42B
$1.68K ﹤0.01%
+26
New +$1.76K
HOMB icon
2869
Home BancShares
HOMB
$6.18B
$1.68K ﹤0.01%
80
-688
-90% -$15.7K
IDYA icon
2870
IDEAYA Biosciences
IDYA
$3.56B
$1.67K ﹤0.01%
62
RES icon
2871
RPC Inc
RES
$1.3B
$1.63K ﹤0.01%
182
PRIM icon
2872
Primoris Services
PRIM
$4.45B
$1.63K ﹤0.01%
49
MYGN icon
2873
Myriad Genetics
MYGN
$312M
$1.62K ﹤0.01%
101
OLPX
2874
DELISTED
Olaplex Holdings
OLPX
$1.61K ﹤0.01%
828
+209
+34% +$629
IMXI icon
2875
International Money Express
IMXI
$367M
$1.61K ﹤0.01%
95
-71
-43% -$1.43K

Similar funds

Parallel Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Parallel Advisors held 3,551 positions worth $3B, down 3.3% from $3.11B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors's Q3 2023 filing shows 192 new, 1,349 increased, 1,018 reduced and 188 closed positions. Its largest new stake was iShares MSCI Intl Quality Factor ETF: 96,005 shares worth $3.23M. The largest sale was iShares International Select Dividend ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q3 2023 buy was iShares MSCI Intl Quality Factor ETF: 96,005 shares worth $3.23M.
  • Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q3 2023, an estimated $38.1M increase.
  • Parallel Advisors's biggest Q3 2023 reduction was iShares International Select Dividend ETF, cutting an estimated $46.2M.
  • Parallel Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $244K.
  • Parallel Advisors's ten largest holdings make up 32% of its $3B portfolio in Q3 2023.
  • Parallel Advisors opened 192 new positions and closed 188 in Q3 2023.
  • Parallel Advisors's portfolio value fell 3.3% quarter-over-quarter to $3B.

Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.